Emil R. Bulatov
Kremlevskaya Street, 18
Kazan, TA 420008, Russian Federation
Kazan, TA 420008, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Peptidomimetic Pillar[5]arene Derivatives Bearing Aromatic α-Amino Acid Fragments as Supramolecular Shields: Preventing Adverse Cyclosporine A-Calcium Ion Interactions.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: July 22, 2026
Allogeneic CAR-T cell therapies: Overcoming clinical challenges and therapeutic potential against tumors.
Journal: Journal of biomedical research
Published: June 21, 2026
Ultrasonication-derived CAR-T vesicles preserve antigen-specific cytotoxic function.
Journal: Frontiers in oncology
Published: May 30, 2026
Emerging Cell-Based Therapies for Systemic Sclerosis: From Stem Cells to CAR-T Cells.
Journal: Current issues in molecular biology
Published: November 11, 2025
Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid Tumors.
Journal: Biomedicines
Published: July 16, 2025
The importance of TP53 status in cancer therapy: The example of chronic lymphocytic leukemia.
Journal: Molecular biology research communications
Published: May 05, 2025
Synthesis, biological and electrochemical evaluation of glycidyl esters of phosphorus acids as potential anticancer drugs.
Journal: Beilstein journal of organic chemistry
Published: April 15, 2025
Future perspectives on novel CAR-T therapeutics beyond CD19 and BCMA in onco-hematology.
Journal: Frontiers in immunology
Published: March 12, 2025
Cellular activity upregulation of the thermolabile p53 cancer mutant Y220C by small molecule indazole derivatives.
Journal: Cell death discovery
Published: February 17, 2025
Allogeneic Treg-derived artificial vesicles: A promising therapeutic modality for multiple sclerosis.
Journal: BioImpacts : BI
Published: December 04, 2024
Last Updated: 09/26/2026